# EDGAR Filing Document

**Accession Number:** 0001592481
**File Stem:** 0001477932-23-001427
**Filing Date:** 2023-3
**Character Count:** 10285
**Document Hash:** 11e3211a3907d9cd4e0e005e75e7b829
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-23-001427.hdr.sgml**: 20230310

**ACCESSION NUMBER**: 0001477932-23-001427

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230310

**DATE AS OF CHANGE**: 20230310

**GROUP MEMBERS**: CATHERINE SALKIND

**GROUP MEMBERS**: GENE SALKIND

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UPEXI, INC.
- **CENTRAL INDEX KEY:** 0001775194
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 833378978
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93404
- **FILM NUMBER:** 23724227

**BUSINESS ADDRESS:**
- **STREET 1:** 17129 US HWY 19 N.
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760
- **BUSINESS PHONE:** 701-353-5425

**MAIL ADDRESS:**
- **STREET 1:** 17129 US HWY 19 N.
- **CITY:** CLEARWATER
- **STATE:** FL
- **ZIP:** 33760

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GROVE, INC.
- **DATE OF NAME CHANGE:** 20190429
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Salkind Gene
- **CENTRAL INDEX KEY:** 0001592481

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**MAIL ADDRESS:**
- **STREET 1:** 1165 WRACK ROAD
- **CITY:** MEADOWBROOK
- **STATE:** PA
- **ZIP:** 19046

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**SCHEDULE 13G**

(Rule 13d-102)

**INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO** 

**§ 240.13d-1(b), (c), and (d) and AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2**

(Amendment No. 1)\*

---

| |
|:---|
| **UPEXI, INC.** |
| (Name of Issuer) |

---

<u>**Common Stock**</u>

(Title of Class of Securities)

<u>**39959A106**</u>

(CUSIP Number)

<u>**December 31, 2022**</u>

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

\*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

<u> CUSIP No. 39959A106</u> 13G <u> Page 2 of 6 Pages</u>

1. NAME OF REPORTING PERSONS Gene Salkind (1)

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐

3. SEC USE ONLY

4. CITIZENSHIP OR PLACE OF ORGANIZATION USA

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 5. | SOLE VOTING POWER<br>94,444 (2) |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 6. | SHARED VOTING POWER<br>2,352,941 (1) |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 7. | SOLE DISPOSITIVE POWER<br>94,444 (2) |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 8. | SHARED DISPOSITIVE POWER<br>2,352,941 (1) |

---

---

| | | |
|:---|:---|:---|
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>2,447,385 (1) (2) |  |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |  |
|  | (SEE INSTRUCTIONS) | ☐ |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>13.56% (3)  |  |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)<br>IN |  |

---

(1) Includes shares of Common Stock of the Issuer titled Gene and Catherine Salkind as joint tendency with survivor rights.

(2) Includes options for the purchase of 94,444 of the Issuer's Common Stock exercisable within 60 days.

(3) Based on 17,960,748 shares of Common Stock as reported in the Issuer's quarterly report as filed with the Commission on February 15, 2023, and 94,444 shares of the Issuer's Common Stock issuable upon the exercise of options.

<u> CUSIP No. 39959A106</u> 13G <u> Page 3 of 6 Pages</u>

1. NAME OF REPORTING PERSONS Catherine Salkind (1)

2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ☐ (b) ☐

3. SEC USE ONLY

4. CITIZENSHIP OR PLACE OF ORGANIZATION USA

---

| | | |
|:---|:---|:---|
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 5. | SOLE VOTING POWER<br>-0- |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 6. | SHARED VOTING POWER<br>2,352,941 (1) |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 7. | SOLE DISPOSITIVE POWER<br>-0- |
| NUMBER OF<br> SHARES<br> BENEFICIALLY<br> OWNED BY<br> EACH<br> REPORTING<br> PERSON<br> WITH | 8. | SHARED DISPOSITIVE POWER<br>2,352,941 (1) |

---

---

| | | |
|:---|:---|:---|
| 9. | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON<br>2,352,941 |  |
| 10. | CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |  |
|  | (SEE INSTRUCTIONS) | ☐ |
| 11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9<br>13.1% (2)  |  |
| 12. | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)<br>IN |  |

---

(1) Includes shares of Common Stock of the Issuer titled Gene and Catherine Salkind as joint tenancy with survivor rights.

(2) Based on 17,960,748 shares of Common Stock as reported in the Issuer's quarterly report as filed with the Commission on February 15, 2023.

<u> CUSIP No. 39959A106</u> 13G <u> Page 4 of 6 Pages</u>

---

| | | |
|:---|:---|:---|
| **Item 1.** |  |  |
|  | (a) | Name of Issuer: Upexi, Inc. |
|  | (b) | Address of Issuer's Principal Executive Offices: |

---

17129 US Hwy 19 N.

Clearwater, FL 33764

---

| | | |
|:---|:---|:---|
| **Item 2.** |  |  |
|  | (a) | Name of Person Filing: Gene and Catherine Salkind |
|  | (b) | Address of Principal Business Office or, if none, Residence: |

---

17129 US Hwy 19 N.

Clearwater, FL 33764

(c) Citizenship or Place of Organization: United States of America

(d) Title of Class of Securities: Common Stock

(e) CUSIP Number: 39959A106

---

| | |
|:---|:---|
| **Item 3.** | **If this statement is filed pursuant to § 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:** |

---

(a) ☐ Broker or dealer registered under Section 15 of the Act.

(b) ☐ Bank as defined in Section 3(a)(6) of the Act.

(c) ☐ Insurance company as defined in Section 3(a)(19) of the Act.

(d) ☐ Investment company registered under Section 8 of the Investment Company Act of 1940.

(e) ☐ An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f) ☐ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g) ☐ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h) ☐ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

(i) ☐ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

(j) ☐ A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

(k) ☐ Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________________________________________.

<u> CUSIP No. 39959A106</u> 13G <u> Page 5 of 6 Pages</u>

---

| | |
|:---|:---|
| **Item 4.** | **Ownership.** |

---

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

---

| | |
|:---|:---|
| (a) | Amount beneficially owned: <br> Gene Salkind 2,447,385 |
|  | Catherine Salkind 2,352,941 |
| (b) | Percent of class: <br> Gene Salkind 13.56%<br> Catherine Salkind 13.1%  |
| (c) | Number of shares as to which the person has: |

---

(i) Sole power to vote or to direct the vote: Gene Salkind 94,444

(ii) Shared power to vote or to direct the vote: Gene Salkind 2,352,941 Catherine Salkind 2,352,941

(iii) Sole power to dispose or to direct the disposition of: Gene Salkind 94,444

(iv) Shared power to dispose or to direct the disposition of: Gene Salkind 2,352,941 Catherine Salkind 2,352,941

---

| | |
|:---|:---|
| **Item 5.** | **Ownership of Five Percent or Less of a Class.** |

---

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐.

---

| | |
|:---|:---|
| **Item 6.** | **Ownership of More than Five Percent on Behalf of Another Person.** |

---

Not Applicable.

---

| | |
|:---|:---|
| **Item 7.** | **Identification and Classification of the Subsidiary Which Acquired the Security** |
|  | **Being Reported on by the Parent Holding Company or Control Person.** |

---

Not Applicable.

---

| | |
|:---|:---|
| **Item 8.** | **Identification and Classification of Members of the Group.** |

---

Not Applicable.

---

| | |
|:---|:---|
| **Item 9.** | **Notice of Dissolution of Group.** |

---

Not Applicable.

---

| | |
|:---|:---|
| **Item 10.** | **Certifications.** |

---

Not Applicable.

<u> CUSIP No. 39959A106</u> 13G <u> Page 6 of 6 Pages</u>

**SIGNATURE**

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| |
|:---|
| March 10, 2023 |
| (Date) |
| */s/ Gene Salkind* |
| (Signature) |
| Gene Salkind |
| (Name/Title) |

---

---

| |
|:---|
| March 7, 2023 |
| (Date) |
| */s/ Catherine Salkind* |
| (Signature) |
| Catherine Salkind |
| (Name/Title) |

---

**Attention: Intentional misstatements or omissions of fact constitute federal criminal violations (*see* 18 U.S.C. 1001).**